BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 15871553)

  • 1. Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
    Purnell JQ; Weyer C
    Treat Endocrinol; 2003; 2(1):33-47. PubMed ID: 15871553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
    Hermansen K; Mortensen LS
    Drug Saf; 2007; 30(12):1127-42. PubMed ID: 18035865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pharmacologic agents for type 2 diabetes.
    Uwaifo GI; Ratner RE
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):155-97. PubMed ID: 15752927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.
    Baron AD; Kim D; Weyer C
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacological development (alpha glucosidase inhibitors, amylin analogues, GLP-1, thiozolidinediones, short acting insulin analogues).
    Dharmalingam M; Kumar P
    J Assoc Physicians India; 2001 Jan; 49 Spec No():46-9. PubMed ID: 11235605
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of insulin secretagogues in the treatment of type 2 diabetes.
    Luna B; Hughes AT; Feinglos MN
    Prim Care; 1999 Dec; 26(4):895-915. PubMed ID: 10523467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral antidiabetic agents in type 2 diabetes.
    Levetan C
    Curr Med Res Opin; 2007 Apr; 23(4):945-52. PubMed ID: 17407651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are you up-to-date on diabetes medications?
    Scemons D
    Nursing; 2007 Jul; 37(7):45-9; quiz 49-50. PubMed ID: 17603373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatments for patients with type 2 diabetes mellitus.
    Wolffenbuttel BH; Graal MB
    Postgrad Med J; 1996 Nov; 72(853):657-62. PubMed ID: 8944206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of diabetes therapy.
    Corathers SD; Peavie S; Salehi M
    Endocrinol Metab Clin North Am; 2013 Dec; 42(4):947-70. PubMed ID: 24286957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.
    Weyer C; Maggs DG; Young AA; Kolterman OG
    Curr Pharm Des; 2001 Sep; 7(14):1353-73. PubMed ID: 11472273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pramlintide in the treatment of diabetes mellitus.
    Edelman S; Maier H; Wilhelm K
    BioDrugs; 2008; 22(6):375-86. PubMed ID: 18998755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments and devices for future diabetes management.
    Capaldi B
    Nurs Times; 2005 May 3-9; 101(18):30-2. PubMed ID: 15892503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs for type 2 diabetes mellitus: what is their place in therapy?
    Krentz AJ; Patel MB; Bailey CJ
    Drugs; 2008; 68(15):2131-62. PubMed ID: 18840004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-insulin pharmacological therapies for treating type 1 diabetes.
    Frandsen CS; Dejgaard TF; Madsbad S; Holst JJ
    Expert Opin Pharmacother; 2018 Jun; 19(9):947-960. PubMed ID: 29991320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of type 1 diabetes mellitus with agents approved for type 2 diabetes mellitus.
    Munir KM; Davis SN
    Expert Opin Pharmacother; 2015; 16(15):2331-41. PubMed ID: 26340427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes medications and body weight.
    Mitri J; Hamdy O
    Expert Opin Drug Saf; 2009 Sep; 8(5):573-84. PubMed ID: 19538102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New potential adjuncts to treatment of children with type 1 diabetes mellitus.
    Raman VS; Heptulla RA
    Pediatr Res; 2009 Apr; 65(4):370-4. PubMed ID: 19092720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis.
    Maggs D; Shen L; Strobel S; Brown D; Kolterman O; Weyer C
    Metabolism; 2003 Dec; 52(12):1638-42. PubMed ID: 14669170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.